Institut de l'oeil des Laurentides

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials
• Diabetic eye disease3 trials
• Glaucoma1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed5 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche4 trials
• Bayer1 trial
• Hexiris Inc1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma

  NCT07358650· Hexiris Inc· Source

  Contact: Janik Denis

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glaucoma1 recruiting

Closed trials

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

  NCT05151744· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Bayer· Source